Pharmacokinetics of meloxicam in rabbit, bird and reptile species
|
|
- Patience Doyle
- 5 years ago
- Views:
Transcription
1 Vet Times The website for the veterinary profession Pharmacokinetics of meloxicam in rabbit, bird and reptile species Author : Elisabetta Mancinelli Categories : Exotics, Vets Date : April 25, 2016 WSAVA has developed global guidelines on the recognition, assessment and management of pain in companion animals ( Image: Fotolia/NiDerLander. Pain is defined as an unpleasant sensory and emotional experience associated with actual or potential tissue damage (IASP, 2015). It is generally accepted any procedure or disease likely to cause pain in human beings, should be expected to cause pain in an animal (Kohn et al, 2007; Lichtenberger and Ko, 2007). Pain can delay healing, lower immune responses and increase morbidity and mortality (Barter, 2011). Appropriate analgesia is, therefore, expected to allow a more rapid return to a normal behaviour in mammals (Hardie et al, 1997). An optimal pain management plan involves the use of multiple drugs, acting at different levels of the pain pathway (multimodal analgesia), so smaller doses of each drug can be used, thereby enhancing pain relief and reducing the likelihood of side effects (Lichtenberger and Ko, 2007; Fisher, 2010). The aim is to improve patient comfort, but also to prevent undesirable effects, such as activation of 1 / 7
2 the sympathetic nervous system, complement cascade, cytokine systems, and arachidonic acid cascade (Barter, 2011), which may result in a variety of pathological outcomes, including tachycardia, hypertension, reduced renal perfusion, hyperglycaemia, altered cardiac output, increase myocardial oxygen demand, altered physiological and endocrinological function, immune system suppression, and pathological lesions. Any attempt, therefore, must be made to reduce pain and stress, including provision of adequate pain relief at appropriate times (pre-emptive analgesia may help reduce pain and postoperative stress; Page et al, 1998). Selection of the appropriate analgesic protocol should include knowledge of pain physiology and the pharmacokinetic properties of that specific drug in a particular species (Kohn et al, 2007; Lichtenberger and Ko, 2007). Therefore, difficulties arise when pharmacokinetic studies for the use of different pain killers in selected species are not known and dosages and/or protocols are extrapolated from one species to another without much consideration for speciesspecific anatomic, physiological and behavioural differences. The major classes of analgesic drugs used for management of acute and chronic pain in exotic animal practice include opioids, NSAIDs and local anaesthetics. Among these, NSAIDs are probably the most commonly prescribed veterinary analgesics. NSAIDs act both centrally and peripherally to block nociception and decrease inflammation, thereby limiting the information directed to the CNS. They exert their therapeutic effect by inhibition of cyclooxygenase (COX) enzymes, which block the conversion of arachidonic acid to pro-inflammatory prostaglandin mediators (Hawkins, 2006). They are generally used to prevent and alleviate acute postoperative and traumatic pain. The main concerns are related to the inhibition of prostaglandins synthesis, which may lead to side effects, such as impaired renal function, gastrointestinal erosions and bleeding disorders (Lichtenberger and Lennox, 2009). The main advantages of using these drugs are their prolonged duration of action and the fact they are not controlled drugs (Lichtenberger and Ko, 2007). Meloxicam has certainly become one of the most commonly used NSAIDs in companion exotic animal medicine. Because of its greater COX-2 selective activity, it may be associated with decreased side effects (for example, inhibition of platelet function, gastrointestinal ulceration and renal function impairment; Jones and Budsberg, 2000). This article aims to review the latest data on meloxicam in selected exotic species. Rabbits Many authors recommend the use of meloxicam in stable normovolaemic animals post-surgery, when they start eating and in the presence of normal renal values, in view of possible intraoperative risks of bleeding and hypotension (Lichtenberger and Ko, 2007). Several studies have been performed to evaluate efficacy, analgesic effects, safety and side effects of meloxicam administered to rabbits at different dosages and via various routes (Turner et al, 2006a and 2006b; 2 / 7
3 Karachalios et al, 2007; Leach et al, 2009; Carpenter et al, 2009; Cooper et al, 2009; Fredholm et al, 2013; Goldschlager et al, 2013; Eshar and Weese, 2014; Delk et al, 2014; Mehraj Khan and Rampal, 2014). Rabbits seem to be able to metabolise meloxicam faster than dogs, humans and rats. The drug appears to be clinically safe in rabbits when used at appropriate dosages, but dosages as high as 1mg/kg may be necessary to achieve a clinically effective concentration in this species. Significant alteration of the hard faecal microbiota did not appear to be a considerable adverse effect in rabbits treated for 21 days with oral meloxicam at a dose of 1mg/kg (Eshar and Weese, 2014). In one study, 1mg/kg followed by 0.5mg/kg was not sufficient to completely control pain after ovariohysterectomy (Leach et al, 2009). Therefore, multimodal analgesia should be considered for the relief of pain associated with this surgery. Avian The pharmacokinetic properties of meloxicam have been evaluated in several avian species, including chickens, ostriches, ducks, turkeys, pigeons (Baert and De Backer, 2003), vultures (Naidoo et al, 2008), ring-necked parakeets (Wilson et al, 2004), Hispaniolan Amazon parrots (Amazona ventralis; Molter et al, 2013), African grey parrots (Psittacus erithacus erithacus; Montesinos et al, 2011), red-tailed hawks (Buteo jamaicensis), and great-horned owls (Bubo virginianus; Lacasse et al, 2013). Cole et al (2009) concluded meloxicam at a dosage of 1mg/kg IM every 12 hours significantly improved weight bearing in Hispaniolan Amazon parrots with experimentally induced arthritis, but a dosage of 0.5mg/kg every 12 hours did not. Other authors focused their research on the adverse effects meloxicam may have on the renal, gastrointestinal, or haemostatic systems in certain avian species (Pereira and Werther, 2007; Montesinos et al, 2009; Desmarchelier et al, 2012; Dijkstra et al, 2015). These studies suggest, despite the fact meloxicam is generally considered a drug with a large therapeutic range and relative safety, compared with other NSAIDs, species-specific dosage, efficacy and potential adverse effects need to be taken into consideration. The simple extrapolation of a dose from one species to another should be done with extreme caution. Therefore, if meloxicam administered at a dose of 1.6mg/kg PO every 12 hours for 15 days has been found to be therapeutic on the basis of pharmacodynamic and pharmacokinetic data available in healthy Hispaniolan Amazon parrots, without resulting in clinical evident adverse effects, the same may not be true for other avian species or unhealthy individuals. Therefore, assessment of specific organ function may be required in some cases to ascertain suitability of meloxicam use for individual patients. Reptiles 3 / 7
4 NSAIDs are also used widely in reptile clinical practice for their analgesic and anti-inflammatory properties; however, only a few pharmacokinetic studies have been published concerning reptile species. Further studies would, therefore, be necessary to evaluate a degree of efficacy and side effects that may vary with the type of NSAIDs selected and the species they are administered. One study evaluated the analgesic efficacy of meloxicam in ball pythons administered at a dose of 0.3mg/kg IM before surgical placement of an arterial catheter showing no physiologic changes (for example, heart rate, blood pressure, plasma epinephrine, and cortisol) indicative of analgesia (Olesen et al, 2008). Another study determined plasma concentrations of meloxicam administered at 0.2mg/kg PO as a single dose to green iguanas were at levels considered analgesic in mammals, and these levels were measurable up to 24 hours after administration, suggesting some effect in this species (Divers et al, 2010). A dose of 0.4mg/kg IM increased the tolerance to an electric stimulus applied to bearded dragons (Greenacre et al, 2008). Pharmacokinetics have also been evaluated in red ear sliders (Trachemys scripta elegans; Rojo-Solis et al, 2009) and yellow-bellied slider turtles (Trachemys scripta scripta; Di Salvo et al, 2015). In this last study, mean blood concentration of meloxicam was above that considered to be effective to induce an anti-inflammatory effect in the horse only when the drug was administered intracoelomically (IC) and IM, but not PO. The data potentially suggests IC and IM administrations as suitable routes for treatment in the turtle. Conversely, the very low plasma concentrations obtained after PO administration could render this route of administration not applicable for turtle treatments. However, the effective therapeutic concentration of meloxicam in turtles is still not known, and further studies are needed to suggest an appropriate dose and administration interval. Clauss et al (2007) and Lai et al (2015) investigated the pharmacokinetics of meloxicam after one dose by IV administration and after parenteral (IV, IM) administration, respectively, to loggerhead sea turtles (Caretta caretta). The latter study found it unlikely meloxicam at 0.1mg/kg is an appropriate choice, particularly in longterm pain management protocols in this species. Unfortunately, the lack of efficacy studies and the few pharmacokinetic investigations published so far with respect to NSAID administration in reptile species, appropriate dosages and frequency of administration can only be extrapolated. However, clinicians aware of the deleterious side effects documented in other species, such as avian and mammalian species (for example, renal impairment, gastrointestinal ulceration/inflammation, haematologic abnormalities), should use these drugs with extreme caution in reptiles too. Due to the complex topic please refer to the literature provided for more in depth 4 / 7
5 References information. Please note meloxicam is used under the cascade. Baert K and De Backer P (2003). Comparative pharmacokinetics of three non-steroidal antiinflammatory drugs in five bird species, Comp Biochem Physiol C Toxicol Pharmacol 134(1): Barter LS (2011). Rabbit analgesia, Vet Clin Exot Anim 14(1): Carpenter JW, Pollock CG, Koch DE and Hunter RP (2009). Single and multiple dose pharmacokinetics of meloxicam after oral administration to the rabbit (Oryctolagus cuniculus), J Zoo Wild Med 40(4): Clauss T, Papich MG, Coy S et al (2007). Pharmacokinetics of meloxicam in loggerhead sea turtles (Caretta caretta) after single dose intravenous administration, Proceedings of the Int Assoc Aqua Anim Med: 228. Cole GA, Paul-Murphy JR, Krugner-Higby L et al (2009). Analgesic effects of intramuscular administration of meloxicam in Hispaniolan parrots (Amazona ventralis) with experimentally induced arthritis, Am J Vet Res 70(12): 1,471-1,476. Cooper CS, Metcalf-Pate KA, Barat CE et al (2009). Comparison of side effects between buprenorphine and meloxicam used postoperatively in Dutch belted rabbits (Oryctolagus cuniculus), J Am Assoc Lab Anim Sci 48(3): Delk KW, Carpenter JW, KuKanich B et al (2014). Pharmacokinetics of meloxicam administered orally to rabbits (Oryctolagus cuniculus) for 29 days, Am J Vet Res 75(2): Desmarchelier M, Troncy E, Fitzgerald G and Lair S (2012). Analgesic effects of meloxicam administration on postoperative orthopedic pain in domestic pigeons (Columba livia), Am J Vet Res 73(3): Dijkstra B, Guzman DS, Gustavsen K et al (2015). Renal, gastrointestinal, and hemostatic effects of oral administration of meloxicam to Hispaniolan Amazon parrots (Amazona ventralis), Am J Vet Res 76(4): Di Salvo A, Giorgi M, Catanzaro A et al (2016). Pharmacokinetic profiles of meloxicam in turtles (Trachemys scripta scripta) after single oral, intracoelomic and intramuscular administrations, J Vet Pharmacol Therap 39(1): Divers SJ, Papich M, McBride M et al (2010). Pharmacokinetics of meloxicam following intravenous and oral administration in green iguanas (Iguana iguana), Am J Vet Res 71(11): 1,277-1,283. Eshar D and Weese JS (2014). Molecular analysis of the microbiota in hard feces from healthy rabbits (Oryctolagus cuniculus) medicated with long term oral meloxicam, BMC Vet Res 10: 62. Fisher PG (2010). Standards of care in the 21st century: the rabbit, J Exot Pet Med 19(1): Fredholm DV, Carpenter JW, KuKanich B and Kohles M (2013). Pharmacokinetics of 5 / 7
6 meloxicam in rabbits after oral administration of single and multiple doses, Am J Vet Res 74(4): Goldschlager GB, Gillespie VL, Palme R and Baxter MG (2013). Effects of multimodal analgesia with low dose buprenorphine and meloxicam on fecal glucocorticoid metabolites after surgery in New Zealand white rabbits (Oryctolagus cuniculus), J Am Assoc Lab Anim Sci 52(5): Greenacre C, Schumaker J and Harvey R (2008). Comparative antinociception of various opioids and non-steroidal antinflammatory medications versus saline in the bearded dragon (Pogona vitticeps) using electrostimulation, Proceedings of the Rept Amph Vet Annu Conf: Hardie EM, Hansen BD and Carroll GS (1997). Behaviour after ovariohysterectomy in the dog: what s normal? Appl Anim Behav Sci 51(1-2): Hawkins MG (2006). The use of analgesics in birds, reptiles and small exotic mammals, J Exot Pet Med 15(3): IASP (2015). Pain, International Association for the Study of Pain ( accessed 2 January 2016). Jones CJ and Budsberg SC (2000). Physiologic characteristics and clinical importance of the cyclooxygenase isoforms in dogs and cats, J Am Vet Med Assoc 217(5): Karachalios T, Boursinos L, Poultsides L et al (2007). The effects of the short-term administration of low therapeutic doses of anti-cox-2 agents on the healing of fractures, an experimental study in rabbits, J Bone Joint Surg Br 89(9): 1,253-1,260. Kohn DF, Martin TE, Foley PL et al (2007). Public statement: guidelines for the assessment and management of pain in rodents and rabbits, J Am assoc Lab Anim Sci 46(2): Lacasse C, Gamble KC and Boothe DM (2013). Pharmacokinetics of a single dose of intravenous and oral meloxicam in red-tailed hawks (Buteo jamaicensis) and great horned owls (Bubo virginianus), J Avian Med Surg 27(3): Lai OR, Di Bello A, Soloperto S et al (2015). Pharmacokinetic behavior of meloxicam in loggerhead sea turtles (Caretta caretta) after intramuscular and intravenous administration, J Wildl Dis 51(2): Leach MC, Allweiler S, Richardson C et al (2009). Behavioural effects of ovariohysterectomy and oral administration of meloxicam in laboratory housed rabbits, Res Vet Sci 87(2): Lichtenberger M and Ko J (2007). Anaesthesia and analgesia for mammals and birds, Vet Clin of Exot Anim 10(2): Lichtenberger M and Lennox AM (2009). Exotic companion mammal emergency medicine and critical care, Proceedings of the Assoc Exot Mam Vet. Mehraj Khan A and Rampal S (2014). Effects of repeated oral administration of pazufloxacin mesylate and meloxicam on the antioxidant status in rabbits, J Am Assoc Lab Anim Sci 53(4): Molter CM, Court MH, Cole GA et al (2013). Pharmacokinetics of meloxicam after intravenous, intramuscular, and oral administration of a single dose to Hispaniolan Amazon parrots (Amazona ventralis), Am J Vet Res 74(3): / 7
7 Powered by TCPDF ( Montesinos A, Ardiaca M, Juan-Selles C et al (2009). Evaluation of the renal effects of meloxicam in African grey parrots (Psittacus erithacus erithacus), Proceedings of the 9th Annu Eur Assoc Avian Vet Conf: Montesinos A, Ardiaca M, Diez-Delgado I et al (2011). Pharmacokinetics of parenteral and oral meloxicam in African grey parrots (Psittacus erithacus erithacus), Proceedings of the 11th Annu Eur Assoc Avian Vet Conf: Naidoo V, Wolter K, Cromarty AD et al (2008). The pharmacokinetics of meloxicam in vultures, J Vet Pharmacol Ther 31(2): Olesen MG, Bertelsen MF, Perry SF and Wang T (2008). Effects of preoperative administration of butorphanol or meloxicam on physiologic responses to surgery in ball pythons, J Am Vet Med Assoc 233(12): 1,883-1,888. Page GG, McDonald JS and Ben-Eliyahu S (1998). Pre-operative versus post-operative administration of morphine: impact on the neuroendocrine, behavioural and metastaticenhancing effect of surgery, Br J Anaesth 81(2): Pereira ME and Werther K (2007). Evaluation of the renal effects of flunixin meglumine, ketoprofen and meloxicam in budgerigars (Melopsittacus undulatus), Vet Rec 160(24): Rojo-Solis C, Ros-Rodriguez J, Valls M et al (2009). Pharmacokinetics of meloxicam after intravenous, intramuscular, and oral administration to red-eared slider turtles (Trachemys scripta elegans), Proceedings of the Am Assoc Zoo Vet Annual Conference: 228. Turner PV, Kerr CL, Healy AJ and Taylor WM (2006a). Effect of meloxicam and butorphanol on minimum alveolar concentration of isoflurane in rabbits, Am J Vet Res 67(5): Turner PV, Chen HC and Taylor WM (2006b). Pharmacokinetic of meloxicam in rabbits after single and repeat oral dosing, Comp Med 56(1): Wilson HG, Hernandez-Divers S, Budsberg SC et al (2004). Pharmacokinetics and use of meloxicam in psittacine birds, Proceedings of the Assoc Avian Vet Annu Meet: / 7
Sea Turtle Analgesics Selection - NSAIDS. Loggerhead Coquina (postoperative ketorolac)
Sea Turtle Analgesics Selection - NSAIDS Craig A. Harms, D.V.M., Ph.D, Dipl. ACZM North Carolina State University Loggerhead Coquina (postoperative ketorolac) $& Sources of Information!! Anecdote!! Expert
More informationNon-steroidal anti-inflammatory drugs (NSAIDs) are used widely to relieve pain, with or without
May 2013 Contents About NSAIDs What about COXselectivity? How effective are NSAIDs? Adverse effects of NSAIDs How frequent are the adverse effects of NSAIDs? General prescribing guidelines for NSAIDs What
More informationEPAR type II variation for Metacam
23 June 2011 EMA/674662/2011 International Non-proprietary Name: Meloxicam Procedure No. EMEA/V/C/033/II/084 EU/2/97/004/026, 33-34 Scope: Type II Addition of indication for cats Page 1/6 Table of contents
More informationN.C. A and T List of Approved Analgesics 1 of 5
1 of 5 Note to user: This list of commonly used analgesics and sedatives is not all-inclusive. The absence of an agent does not necessarily mean it is unacceptable. For any questions, call the Clinical
More informationJust where it s needed.
Relief. Just where it s needed. Tissue-selective 7,8 Strong safety profile 5,6,10,11 For dogs and cats Onsior is available in a range of convenient and easy-to-dose formulations. Injectable solution for
More informationPOST-OPERATIVE ANALGESIA AND FORMULARIES
POST-OPERATIVE ANALGESIA AND FORMULARIES An integral component of any animal protocol is the prevention or alleviation of pain or distress, such as that associated with surgical and other procedures. Pain
More informationSOP #: Page: 1 of 6 Rodent Analgesia
Comparative Medicine Page: 1 of 6 Rodent Analgesia The intent of this Standard Operating Procedure (SOP) is to describe commonly used analgesics provided to rodents housed at Comparative Medicine (CM).
More informationMetacam 1.5 mg/ml oral suspension for dogs
Metacam 1.5 mg/ml oral suspension for dogs Species:Dogs Therapeutic indication:pharmaceuticals: Neurological preparations: Analgesics, Other NSAIDs, Locomotor (including navicular and osteoarthritis) Active
More informationMetacam. The Only NSAID Approved for Cats in the US. John G. Pantalo, VMD Professional Services Veterinarian. Think easy. Think cat. Think METACAM.
Metacam The Only NSAID Approved for Cats in the US John G. Pantalo, VMD Professional Services Veterinarian Think easy. Think cat. Think METACAM. Today s Agenda New pain management guidelines for cats Only
More informationSUMMARY OF PRODUCT CHARACTERISTICS. 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Emdocam 20 mg/ml solution for injection for cattle, pigs and horses
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Emdocam 20 mg/ml solution for injection for cattle, pigs and horses 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One ml contains:
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Rycarfa 100 mg tablets for dogs (BE, DE, ES, FR, IE, IT, NL, PT, UK) Rycarfa vet 100 mg tablets for dogs (DK, FI) Carprox
More informationThe effects of two non-steroidal anti-inflammatory drugs on the mobility of laying hens with keel bone fractures
Veterinary Anaesthesia and Analgesia, 2015, 42, 197 204 doi:10.1111/vaa.12175 RESEARCH PAPER The effects of two non-steroidal anti-inflammatory drugs on the mobility of laying hens with keel bone fractures
More informationProcedure # IBT IACUC Approval: December 11, 2017
IACUC Procedure: Anesthetics and Analgesics Procedure # IBT-222.04 IACUC Approval: December 11, 2017 Purpose: The purpose is to define the anesthetics and analgesics that may be used in mice and rats.
More informationSummary of Product Characteristics
Summary of Product Characteristics 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Melosolute 20 mg/ml solution for injection for cattle, pigs and horses. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION One ml contains:
More informationSummary of Product Characteristics
Summary of Product Characteristics 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Melosolute 5 mg/ml solution for injection for cattle, pigs, dogs and cats. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION One ml
More informationPain Management in Racing Greyhounds
Pain Management in Racing Greyhounds Pain Pain is a syndrome consisting of multiple organ system responses, and if left untreated will contribute to patient morbidity and mortality. Greyhounds incur a
More informationCommonly Used Analgesics
Commonly Used Analgesics The following analgesics are intended for general use in the species of laboratory animals commonly used at NEOUCOM. The animals genetic background and other factors may have a
More informationMeloxicam vs etodolac cox 2 inhibition
Meloxicam vs etodolac cox 2 inhibition The Borg System is 100 % Meloxicam vs etodolac cox 2 inhibition of GI. Aspirin inhibits plt aggregration via inhibition of platelet COX. Meloxicam least. Etodolac
More informationWelcome to. Who Wants to be a Millionaire 50:50
0:0 Welcome to Who Wants to be a Millionaire 0 $ Million $,000 $,000 $00 0 $ Million $,000 $,000 $00 What is the generic name for the drug in Ketofen? C:Ketoprofen 0:0 0 $ Million $,000 $,000 $00 A: Ketarian
More informationStart of new generation of NSAIDs?
Vet Times The website for the veterinary profession https://www.vettimes.co.uk Start of new generation of NSAIDs? Author : Peter Lees Categories : Vets Date : May 16, 2011 Peter Lees discusses development
More informationInflammatory pain in cattle
Inflammatory pain in cattle Stine Jacobsen Professor of Large Animal Surgery Dept. of Veterinary Clinical Sciences 2 Inflammation an everyday occurrence 1 3 Inflammation an everyday occurrence 4 Inflammation
More informationThe Institutional Animal Care and Use Committee (IACUC) Aquatic Animals: Analgesia and Anesthesia formulary
The Institutional Animal Care and Use Committee (IACUC) Aquatic Animals: Analgesia and Anesthesia formulary The appropriate use of pain medications (analgesics) and anesthetics is a critical aspect of
More informationT u l a n e U n i v e r s i t y I A C U C Guidelines for Rodent & Rabbit Anesthesia, Analgesia and Tranquilization & Euthanasia Methods
T u l a n e U n i v e r s i t y I A C U C Guidelines for Rodent & Rabbit Anesthesia, Analgesia and Tranquilization & Euthanasia Methods Abbreviations: General Considerations IV = intravenous SC = subcutaneous
More informationSummary of Product Characteristics
Summary of Product Characteristics 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Rifen 100 mg/ml solution for injection for horses, cattle and swine. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml contains:
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS. Medicinal product no longer authorised
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Zubrin 50 mg oral lyophilisates for dogs Zubrin 100 mg oral lyophilisates for dogs Zubrin 200 mg oral lyophilisates
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/33
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/33 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Acticam 1.5 mg/ml oral suspension for dogs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml of Acticam 1.5
More informationThe new meloxicam range for cattle, pigs & horses
The new meloxicam range for cattle, pigs & horses Melovem 5 mg/ml Melovem 20 mg/ml Melovem 30 mg/ml The new Melovem range + Many indications for cattle, horses and pigs + Accurate dosing Dopharma has obtained
More informationUNTHSC. Institutional Animal Care and Use Committee. Title: Analgesics and Anesthesia in Laboratory Animals at UNTHSC. Document #: 035 Version #: 02
Institutional Animal Care and Use Committee Title: Analgesics and Anesthesia in Laboratory Animals at UNTH Document #: 035 Version #: 02 UNTH Approved by IACUC Date: August 22, 2017 A. BACKGROUND INFORMATION
More informationSUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT
SUMMARY OF PRODUCT CHARACTERISTICS Revised: December 2013 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Flunixin 50 mg/ml Solution for Injection for Cattle, Horses and Pigs (United Kingdom, Germany, Iceland)
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT AT, BE, BG, CY, CZ, DE, EE, EL, ES, FR, HR, HU, IE, IT, LT, LU, NL, PT, RO, SK, UK: Kelaprofen 100 mg/ml, solution for injection
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT NEFOTEK 100 mg/ml solution for injection for cattle, horses and pigs [AT, CZ, IE, PL, SK, UK, DE, FR, ES, HU, IT, SI] COXOFEN
More informationMetacam is an anti-inflammatory medicine used in cattle, pigs, horses, dogs, cats and guinea pigs.
EMA/CVMP/259397/2006 EMEA/V/C/000033 An overview of Metacam and why it is authorised in the EU What is Metacam and what is it used for? Metacam is an anti-inflammatory medicine used in cattle, pigs, horses,
More informationSUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Carprodyl Quadri 120 mg chewable tablets for dogs Carprodyl vet. 120 mg chewable tablets for dogs (FI, SE, DK) 2. QUALITATIVE
More informationSUMMARY OF PRODUCT CHARACTERISTICS. Animeloxan 1.5 mg/ml oral suspension for dogs. Active substance: Meloxicam 1.5 mg (equivalent to 0.
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Animeloxan 1.5 mg/ml oral suspension for dogs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml of suspension contains:
More informationNSAIDs: the Past, Present, and Future
NSAIDs: the Past, Present, and Future Resident Seminar - November 2017 Lisanne Gallant, DVM Large Animal Medicine Resident Outline Physiology Review Use in Large Animals Adverse Effects Cases The Future
More informationAustralian and New Zealand College of Veterinary Scientists. Fellowship Examination. Veterinary Anaesthesia and Critical Care Paper 1
Australian and New Zealand College of Veterinary Scientists Fellowship Examination June 2016 Veterinary Anaesthesia and Critical Care Paper 1 Perusal time: Twenty (20) minutes Time allowed: Three (3) hours
More informationTransition cows have decreased immune function. The transition period. Inflammation, Immune Function, and the Transition Cow.
Overview Inflammation, Immune Function, and the Transition Cow Barry Bradford Kansas State University Herd Health & Nutrition Conferences April 2016 Immunity and inflammation in the transition cow Long
More informationFinal Report. Project code: P.PSH.0653 Prepared by: Fiona Cotter Troy Laboratories Pty Ltd Date published: July 2014
Final Report Project code: P.PSH.0653 Prepared by: Fiona Cotter Troy Laboratories Pty Ltd Date published: July 2014 PUBLISHED BY Meat & Livestock Australia Limited Locked Bag 991 NORTH SYDNEY NSW 2059
More informationPain management in equine patients therapy options
Vet Times The website for the veterinary profession https://www.vettimes.co.uk Pain management in equine patients therapy options Author : Tom Hughes Categories : Equine, Vets Date : July 13, 2015 Drugs
More informationDepartment of Laboratory Animal Resources. Veterinary Recommendations for Anesthesia and Analgesia
Department of Laboratory Animal Resources Guideline Veterinary Recommendations for Anesthesia and Analgesia A. PRINCIPLES OF ANESTHESIA AND ANALGESIA 1. The proper anesthetic and analgesic agents must
More informationCopyright is owned by the Author of the thesis. Permission is given for a copy to be downloaded by an individual for the purpose of research and
Copyright is owned by the Author of the thesis. Permission is given for a copy to be downloaded by an individual for the purpose of research and private study only. The thesis may not be reproduced elsewhere
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Metacam 5 mg/ml solution for injection for cattle and pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One ml contains:
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Metacam 5 mg/ml solution for injection for cattle and pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One ml contains:
More informationPain Management Future pain relief options. Ian Colditz CSIRO Animal, Food and Health Sciences Armidale NSW 2350
Pain Management Future pain relief options Ian Colditz CSIRO Animal, Food and Health Sciences Armidale NSW 2350 A national flystrike R&D technical update 1 st August 2012 Animal Experimentation The Principles
More informationFaculty of Veterinary Science, Szent Istvan University Department of Pharmacology and Toxicology. Nora Line
Faculty of Veterinary Science, Szent Istvan University Department of Pharmacology and Toxicology Meloxicam usage in cats, and its potential adverse effects on the renal function Nora Line Tutor: György
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Novem 5 mg/ml solution for injection for cattle and pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One ml contains:
More informationNon-steroidal anti-inflammatory drugs in dogs and cats what s new?
continuing education Nonsteroidal antiinflammatory drugs in dogs and cats what s new? Isabelle Iff Dr.med.vet. DipECVAA CertVetAc (IVAS) Veterinary Anaesthesia Services Zürcherstrasse 39 CH 8400 Winterthur
More informationAnaesthesia and Analgesia of fish
Anaesthesia and Analgesia of fish Dr Stewart Fielder Port Stephens Fisheries Institute Marine fish production and enhancement Plan of talk Who uses anaesthetics for fish Why anaesthetics are used When
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Loxicom 0.5 mg/ml oral suspension for dogs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: Active
More informationMeloxicam: a review of its pharmacokinetics, efficacy and tolerability following intramuscular administration
Inflamm. res. 50, Supplement 1 (2001) S5 S9 1023-3830/01/01S5-05 $ 1.50+0.20/0 Birkhäuser Verlag, Basel, 2001 Inflammation Research Meloxicam: a review of its pharmacokinetics, efficacy and tolerability
More informationEffect of non-steroidal anti-inflammatory drugs on the blood profile in the green iguana (Iguana iguana)
Veterinarni Medicina, 52, 2007 (): 507 5 Effect of non-steroidal anti-inflammatory drugs on the blood profile in the green iguana (Iguana iguana) S. Trnkova, Z. Knotkova, A. Hrda, Z. Knotek Faculty of
More informationDose-related thermal antinociceptive effects of intravenous hydromorphone in cats
Veterinary Anaesthesia and Analgesia, 2007, 34, 132 138 doi:10.1111/j.1467-2995.2006.00311.x RESEARCH PAPER Dose-related thermal antinociceptive effects of intravenous hydromorphone in cats Kirsten Wegner
More informationOptimizing Pain Control A Critical Understanding of NSAIDs
Optimizing Pain Control A Critical Understanding of NSAIDs James S. Gaynor, DVM, MS, DACVA, DAAPM Colorado Springs, CO USA 719-266-6400 800-791-2578 www.peakvets.com Principles of Acute & Chronic Pain
More informationMobility Issues and Arthritis
Mobility Issues and Arthritis 1. Overview of end stage of the disease. Mobility issues are often attributed to normal aging by pet owners, and can have insidious symptoms as they may progress slowly without
More informationVeterinary Medicinal Product
Veterinary Medicinal Product Carprodyl Quadri 120 mg chewable tablets for dogs PART I B Pharmaceutical Form Chewable tablet Veterinary Medicinal Product Carprodyl Quadri 120mg chewable tablets for dogs
More informationAlfaxalone use in selected exotic species part 1
Vet Times The website for the veterinary profession https://www.vettimes.co.uk Alfaxalone use in selected exotic species part 1 Author : Elisabetta Mancinelli Categories : Exotics, Vets Date : September
More informationOptimized surgical techniques and postoperative care
Optimized surgical techniques and postoperative care Margarete Arras PD Dr. med. vet. DipECLAM University Hospital Zurich Center for Clinical Reserach Division of Surgical Research Optimized surgical techniques
More informationCaution: Federal law restricts this drug to use by or on the order of a licensed veterinarian.
BOEHRINGER INGELHEIM VETMEDICA, INC. USA Product Label http://www.vetdepot.com 2621 NORTH BELT HIGHWAY, ST. JOSEPH, MO, 64506 2002 Telephone: 800 325 9167 Fax: 816 236 2717 Email: www.bi vetmedica.com
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/127
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/127 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Metacam 5 mg/ml solution for injection for cattle and pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One ml
More informationIs Robenacoxib Superior to Meloxicam in Improving Patient Comfort in Dog Diagnosed With a Degenerative Joint Process?
Is Robenacoxib Superior to Meloxicam in Improving Patient Comfort in Dog Diagnosed With a Degenerative Joint Process? A Knowledge Summary by Adam Swallow BVSc MRCVS 1* 1 University of Bristol * Corresponding
More informationMouse Formulary. The maximum recommended volume of a drug given depends on the route of administration (Formulary for Laboratory Animals, 3 rd ed.
Mouse Formulary The maximum recommended volume of a drug given depends on the route of administration (Formulary for Laboratory Animals, 3 rd ed.): Intraperitoneal (IP) doses should not exceed 80 ml/kg
More informationModule C Veterinary Anaesthesia Small Animal Anaesthesia and Analgesia (C-VA.1)
Module C Veterinary Anaesthesia Small Animal Anaesthesia and Analgesia (C-VA.1) Module Leader - Elizabeth Armitage-Chan MA Vet MB DipACVA MRCVS RCVS Specialist in Veterinary Anaesthesia The aim of the
More informationNSAID Toxicity in Dogs & Cats Beware of Ibuprofen!
NSAID Toxicity in Dogs & Cats Beware of Ibuprofen! One of the most common drug toxicities in companion animal medicine is accidental ingestion of over-the-counter non-steroid anti-inflammatory (NSAID)
More informationAustralian and New Zealand College of Veterinary Scientists. Membership Examination June Veterinary Pharmacology Paper 1
Australian and New Zealand College of Veterinary Scientists Membership Examination June 2012 Veterinary Pharmacology Paper 1 Perusal time: Fifteen (15) minutes Time allowed: Two (2) hours after perusal
More information[09/2018] ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
[09/2018] ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Cronyxin 50 mg/g Oral paste for horses (DE, AT, BE, EE, LV, LT, ES, FR, IE, IT, NL, PL, UK) Cronyxin vet
More informationScientific Discussion post-authorisation update for Rheumocam extension X/007
5 May 2011 EMA/170257/2011 Veterinary Medicines and Product Data Management Scientific Discussion post-authorisation update for Rheumocam extension X/007 Scope of extension: addition of 20 mg/ml solution
More informationPain management: making the most of the latest options
Vet Times The website for the veterinary profession https://www.vettimes.co.uk Pain management: making the most of the latest options Author : James Westgate Categories : Business, Business planning Date
More informationUniversity of Bristol - Explore Bristol Research
Hothersall, B., Caplen, G. J., Parker, R. M. A., Nicol, C. J., Waterman- Pearson, A. E., Weeks, C. A., & Murrell, J. C. (2016). Effects of carprofen, meloxicam and butorphanol on broiler chickens performance
More informationDECISION AND SECTION 43 STATEMENT TO THE VETERINARY COUNCIL BY THE COMPLAINTS ASSESSMENT COMMITTEE: CAC Dr A. (Section 39 referral/complaint)
DECISION AND SECTION 43 STATEMENT TO THE VETERINARY COUNCIL BY THE COMPLAINTS ASSESSMENT COMMITTEE: CAC15-07 Dr A (Section 39 referral/complaint) Dr A B Dr C Veterinarian Clinic where Dr A works Former
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Meloxidyl 1.5 mg/ml oral suspension for dogs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Composition for 1 ml Active
More informationWhat dose of methadone should I use?
What dose of methadone should I use? Professor Derek Flaherty BVMS, DVA, DipECVAA, MRCA, MRCVS RCVS and European Specialist in Veterinary Anaesthesia SPC dose rates for Comfortan dogs: 0.5-1.0 mg/kg SC,
More informationNSAIDs Are You Following the Rules?
NSAIDs Are You Following the Rules? As equestrians, we expect a lot from our performance horses. Sometimes pain and inflammation of their joints can happen right before a show or competition. Before administering
More informationDexmedetomidine and its Injectable Anesthetic-Pain Management Combinations
Back to Anesthesia/Pain Management Back to Table of Contents Front Page : Library : ACVC 2009 : Anesthesia/Pain Management : Dexmedetomidine Dexmedetomidine and its Injectable Anesthetic-Pain Management
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Rheumocam 1.5 mg/ml oral suspension for dogs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One ml contains: Active
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Rheumocam 1.5 mg/ml oral suspension for dogs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One ml contains: Active
More informationMeloxicam withdrawal time veterinarian bovine
Meloxicam withdrawal time veterinarian bovine The Borg System is 100 % Meloxicam withdrawal time veterinarian bovine Meloxicam Pain Relief in Cows and Calves. Meloxicam meat and milk withdrawal the standard
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Meloxidyl 1.5 mg/ml oral suspension for dogs. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Composition for 1 ml Active
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Inflacam 1.5 mg/ml oral suspension for dogs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One ml contains: Active
More informationPremedication with alpha-2 agonists procedures for monitoring anaesthetic
Vet Times The website for the veterinary profession https://www.vettimes.co.uk Premedication with alpha-2 agonists procedures for monitoring anaesthetic Author : Lisa Angell, Chris Seymour Categories :
More informationAustralian and New Zealand College of Veterinary Scientists. Membership Examination. Veterinary Anaesthesia and Critical Care Paper 1
Australian and New Zealand College of Veterinary Scientists Membership Examination June 2015 Veterinary Anaesthesia and Critical Care Paper 1 Perusal time: Fifteen (15) minutes Time allowed: Two (2) hours
More informationThe Influence of a Combined Butorphanol and Midazolam Pre-medication on Anaesthesia in Psittacid Species
The Influence of a Combined Butorphanol and Midazolam Pre-medication on Anaesthesia in Psittacid Species Dissertation submitted in part fulfilment of the requirements for the Royal College of Veterinary
More informationPain Management in Livestock
Pain Management in Livestock Definition of pain There is no simple definition of pain and the association with disease is complex. Pain has been defined as an unpleasant, sensory experience representing
More informationProceedings of the International Congress of the Italian Association of Companion Animal Veterinarians
www.ivis.org Proceedings of the International Congress of the Italian Association of Companion Animal Veterinarians June 8-10, 2012 - Rimini, Italy Next SCIVAC Congress: Mar. 8-10, 2013 Pisa, Italy SCIVAC
More informationIrish Medicines Board
IRISH MEDICINES BOARD ACT 1995 EUROPEAN COMMUNITIES (ANIMAL REMEDIES) (No. 2) REGULATIONS 2007 (S.I. No. 786 of 2007) VPA:10778/003/002 Case No: 7003735 The Irish Medicines Board in exercise of the powers
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Inflacam 1.5 mg/ml oral suspension for dogs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One ml contains: Active
More informationThe world s first and only pour-on anti-inflammatory for cattle FAST PAIN RELIEF
The world s first and only pour-on anti-inflammatory for cattle FAST PAIN RELIEF NOTHING IS SIMPLER THAN POUR-ON RELIEF FOR PAIN, FEVER AND ACUTE INFLAMMATION easy to dose easy to apply easy on animals
More informationNUMBER: R&C-ARF-10.0
1. PURPOSE PAGE 1 OF 6 This policy describes the procedures for keeping and maintaining animal medical records. This procedure is approved by the Creighton University Institutional Animal Care and Use
More informationDECISION AND SECTION 43 STATEMENT TO THE VETERINARY COUNCIL BY THE COMPLAINTS ASSESSMENT COMMITTEE: CAC15-08
DECISION AND SECTION 43 STATEMENT TO THE VETERINARY COUNCIL BY THE COMPLAINTS ASSESSMENT COMMITTEE: CAC15-08 Dr A (Section 39 referral/complaint) Dr A B Dr C Veterinarian Clinic where Dr A works Former
More informationDREXEL UNIVERSITY COLLEGE OF MEDICINE ANIMAL CARE AND USE COMMITTEE POLICY FOR PREOPERATIVE AND POSTOPERATIVE CARE FOR NON-RODENT MAMMALS
DREXEL UNIVERSITY COLLEGE OF MEDICINE ANIMAL CARE AND USE COMMITTEE POLICY FOR PREOPERATIVE AND POSTOPERATIVE CARE FOR NON-RODENT MAMMALS OBJECTIVE: This policy is to ensure that appropriate provisions
More informationTreatment of septic peritonitis
Vet Times The website for the veterinary profession https://www.vettimes.co.uk Treatment of septic peritonitis Author : Andrew Linklater Categories : Companion animal, Vets Date : November 2, 2016 Septic
More informationCompanion Animal Fund Research Projects
Companion Animal Fund Research Projects - 2016 Genomic, Phylogenetic, and Recombinational Characterization of Feline Herpesvirus Field Isolates Using Deep-Sequencing Technology Ellison Bentley, clinical
More informationProfessor David J Mellor Professor Kevin J Stafford Co-Directors
Professor David J Mellor Professor Kevin J Stafford Co-Directors Collaborating Centre for Animal Welfare Science and Bioethical Analysis: Founding Partner http://animalwelfare.massey.ac.nz Evolving Veterinary
More informationAustralian College of Veterinary Scientists Fellowship Examination. Veterinary Anaesthesia and Critical Care Paper 1
Australian College of Veterinary Scientists Fellowship Examination June 2011 Veterinary Anaesthesia and Critical Care Paper 1 Perusal time: Twenty (20) minutes Time allowed: Three (3) hours after perusal
More informationAntimicrobial utilization: Capital Health Region, Alberta
ANTIMICROBIAL STEWARDSHIP Antimicrobial utilization: Capital Health Region, Alberta Regionalization of health care services in Alberta began in 1994. In the Capital Health region, restructuring of seven
More informationProceedings of the Southern European Veterinary Conference - SEVC -
www.ivis.org Proceedings of the Southern European Veterinary Conference - SEVC - Sep. 29-Oct. 2, 2011, Barcelona, Spain Next SEVC Conference: Oct. 18-21, 2012 - Barcelona, Spain Reprinted in the IVIS website
More informationNUMBER: /2005
Purpose PAGE 1 OF 7 The purpose of this policy is to describe the procedures for keeping and maintaining animal medical records. This procedure is approved by the Creighton University Institutional Animal
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Onsior 6 mg tablets for cats 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains: Active substance:
More informationINTRODUCTION TO WILDLIFE PHARMACOLOGY. Lisa Fosco Wildlife Rehabilitation Manager Toronto Wildlife Centre
INTRODUCTION TO WILDLIFE PHARMACOLOGY Lisa Fosco Wildlife Rehabilitation Manager Toronto Wildlife Centre General Pharmacology Factors That Affect Drug Absorption The dosage form Blood supply to the area
More informationAcute Hemorrhagic Diarrhea Syndrome (AHDS) A Cause of Bloody Feces in Dogs
Acute Hemorrhagic Diarrhea Syndrome (AHDS) A Cause of Bloody Feces in Dogs No dog parent wants to clean up diarrhea. Cleaning up bloody diarrhea is even more unpleasant. Unfortunately, the development
More informationRefinement Issues in Animal Research. Joanne Zurlo, PhD Institute for Laboratory Animal Research National Academy of Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this
More information